This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
July 28, 2017
Onxeo Reports First-Half 2017 Results and Business Update
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 24, 2017
Targovax ASA: Completion of subsequent offering\, registration of share capital increase
July 21, 2017
Exercise of over-allotment option and end of the stabilization period
July 17, 2017
Targovax ASA: Final result of the subsequent offering
July 17, 2017
Strongbridge Biopharma plc Secures $53 Million Financing From CRG
July 14, 2017
Q2 2017 General Market Overview